Responding to an Activist Campaign: A Practical Guide

Document type: Guide Practice area: Corporate — Governance Jurisdiction: United States (federal and state) Last reviewed: 5 September 2026

Who this is for

The general counsel of a public company that has just seen unusual accumulation, or a Schedule 13D, or a letter.

Our example is Pemberton Materials, a $1.8 billion market capitalization specialty chemicals company with three segments and three years of underperformance against its peer group. Its general counsel is Yusuf Delacroix-Mbeki.

The organizing principle: the audience is the company's own shareholders, and most of what determines the outcome happened before the activist appeared.

Step 1 — Do the preparedness work in ordinary years

Know your register. Stock surveillance identifying accumulations, quarterly institutional holdings analysis, and a current picture of who owns the company. A company surprised by its own shareholder base has already lost weeks.

Run the activist's analysis on yourself, annually. Total shareholder return against peers and the index. Segments worth more separately. Capital allocation record. Margin performance versus comparable operators. Governance features an adviser would criticize. Board tenure, composition, and skills. Executive compensation against performance.

Then act on what it finds. Refresh the board where tenure or skills are weak. Address the underperforming segment. Adjust compensation. Improve the strategy disclosure. Every remediated issue is an argument that cannot be made.

Build institutional relationships when nothing is happening. Meet the governance teams, not only the portfolio managers, at the largest index holders. Understand each major holder's voting policies. This is the single highest-return preparedness activity and it is nearly free.

Keep the infrastructure ready: advance notice bylaws reviewed and current; a rights plan on the shelf; a named response team; a proxy solicitor, financial adviser, and outside counsel identified and briefed; and a board that has discussed what it would do.

Run a tabletop. A simulated 13D, with the team working the first seventy-two hours. It reveals who is missing from the plan.

Step 2 — The first seventy-two hours

Convene the named response team: chief executive, chief financial officer, general counsel, investor relations, outside counsel, financial adviser, proxy solicitor, communications counsel.

Read the filing carefully. Percentage, when acquired and at what prices, how funded, and — most importantly — what the stated purpose discloses. A Schedule 13D under 15 U.S.C. § 78m(d) that discloses plans regarding board composition or a strategic transaction is a different matter from one that does not.

Brief the board within twenty-four hours, in writing, with the filing attached and a preliminary assessment. A director who learns of the campaign from the press becomes difficult to manage.

Say something short and neutral. The company welcomes input from shareholders and is committed to acting in the interests of all of them. Silence reads as unpreparedness; a defensive statement reads as entrenchment. Nothing more substantive until the board has met.

Do not: attack the activist personally; adopt a defensive measure reflexively; make a hasty strategic announcement that looks like a response; or let an executive respond publicly without approval.

Start surveillance and register work immediately — who else is accumulating, what the base looks like now, and which holders to call first.

And check the calendar. The advance notice window, the nomination deadline, and the annual meeting date set the timetable for everything. Diarize them before anything else.

Step 3 — Assess the substance honestly, in private

This is the step boards skip and the one that determines whether the response is credible.

In a privileged session, ask: which of the activist's arguments are right? Not "how do we rebut this" — which of these would we accept from a director?

Pemberton's board found two of four arguments persuasive: the specialty coatings segment did earn materially higher returns and was probably worth more separately, and three directors had served over fourteen years with no relevant operating experience. The board had reached similar conclusions in its own assessment nine months earlier and had not acted.

Separate the arguments into three categories. Right, and we should act. Wrong, and we can demonstrate it with data. Contested, and reasonable people differ.

Then decide what the company would do anyway. A change the board believes is correct should be made because it is correct — and announced on the company's own reasoning, not as a concession. A board that adopts the activist's proposal while claiming it was already planned, without a record, is not believed.

Assess the conflicts. Where management's position is at issue, consider whether the response should be directed by a committee of independent directors with its own advisers. In any campaign that includes a call for a sale, it should be.

And document the deliberation. Minutes that record what was considered, on what advice, are the record that will be produced.

Step 4 — Handle the nomination notice correctly

Read the advance notice bylaws and the notice against them, carefully.

Check completeness: timeliness within the window; the nominating holder's ownership including derivative and short positions; arrangements and understandings with others; each nominee's background and qualifications; any third-party compensation arrangement between the nominee and the nominating fund; and the required representations.

Then decide whether to challenge — and be conservative. Rejecting a valid nomination on a strained reading is the second most dangerous thing a company can do in a campaign, because it becomes litigation the company loses in public and hands the activist a governance argument.

Where a notice is genuinely defective, engage rather than reject silently: identify the deficiency in writing and give the holder an opportunity to respond. The record matters more than the technicality.

Do not amend the bylaws now. Amending advance notice provisions after a nomination or a 13D is a defensive measure evaluated as such, and courts have invalidated provisions adopted or applied inequitably in the face of a specific threat.

Then read the derivative disclosure closely. A holder whose economic exposure is smaller than its share position suggests — or who is hedged — is a holder whose thesis reads differently, and that is a point worth making to shareholders.

Step 5 — Build the vote model

A contest is arithmetic. Build the model in week two, not week ten.

Holder by holder, for the top fifty positions: shares, percentage, holder type, likely disposition, what would change it, who owns the relationship, and whether the governance team or the portfolio manager decides.

Understand where the votes actually are. The index funds are usually the largest holders, vote everything, and decide through governance teams applying published policies. Active managers are fewer and more persuadable in either direction. The proxy advisers do not vote but move a meaningful share of institutional votes. The retail base votes at a low rate, tends to support management, and is expensive to reach — which is where the solicitor earns its fee.

Model the mechanics too: record date timing, broker non-vote treatment, the ability of holders to change a submitted proxy, and employee plan shares with their pass-through arrangements.

Then note the standard. Under a plurality standard in a contested election, the highest vote-getters win regardless of majority support — so the number of seats up, and whether the board is staggered, changes the arithmetic entirely.

Under universal proxy, model each seat separately. Shareholders can now mix, so the question is not "will we win the slate" but "which of our nominees is individually weakest against which of theirs." A fourteen-year director with no relevant operating experience is a specific, identifiable vulnerability.

Update the model weekly as engagement proceeds. It is the campaign plan.

Step 6 — Engage institutions and the advisers

Call the largest holders in the first two weeks, before the activist's narrative settles. Ask what they think, and listen — holders frequently say exactly what would change their vote.

Meet the governance teams, not only the portfolio managers, at the index funds. They apply published policies; know what those policies say about board tenure, classification, compensation, and responsiveness to shareholder proposals, and address them directly.

Prepare a substantive submission for the proxy advisers. They are analytical, they read the record, and they weigh performance, governance, and nominee quality rather than rhetoric. Treat the engagement as seriously as the largest holder meeting, and submit early enough to be considered.

Lead with data, not tone. Segment economics, the capital allocation record with returns, the board skills matrix, and the specific steps taken. A response that engages the arguments persuades; one that questions the activist's motives signals no answer on the merits.

Never attack personally. It reads as entrenchment, alienates holders who agree with the substance, and is the most common unforced error in these campaigns.

Correct errors once, precisely, with the source — and do not litigate every characterization. The audience stops reading.

And remember every communication is a solicitation under Section 14(a), 15 U.S.C. § 78n(a) and the rules at 17 C.F.R. Part 240, must be filed, and is subject to the antifraud provision. One approval path, one named approver, nothing out without both — including executive social media.

Step 7 — Decide whether to settle

The honest test: would we appoint these people if the fund did not exist?

If the nominees are genuinely strong and the board would benefit, take them and stop spending. If they are not, be prepared to run the contest — and be confident, from the vote model, that you will win.

Do not settle to avoid embarrassment, and do not fight to avoid the appearance of capitulation. Both are decisions made about the board rather than about the company.

The terms to negotiate:

Board composition. How many seats, who fills them, and whether an independent mutually agreed director is added alongside the activist's nominee. Committee membership is the hardest term and the one that determines actual influence.

The standstill. Duration — typically tied to the next nomination window; no further nominations, proposals, or solicitations; a cap on accumulation; and no group formation with others.

Voting commitments. A commitment on director elections is ordinary; one covering all matters is aggressive and draws adviser criticism.

Information rights and confidentiality — specifically, whether the appointed director may share board information with the fund, and the fund's resulting trading restrictions. Address this expressly; it is the recurring conflict.

Non-disparagement, mutual and time-limited. Termination and fall-away provisions. Expense reimbursement, which activists routinely request.

And announce it properly — on the company's reasoning, with the substantive commitments the company intends to keep.

Step 8 — If you use defensive measures, understand the scrutiny

A rights plan on the shelf is standard practice; an outstanding plan draws governance criticism and adviser opposition. Adopting one in response to accumulation is a defensive measure subject to enhanced scrutiny.

The Delaware framework asks whether the board identified a legitimate threat after reasonable investigation and whether the response was proportionate. The investigation — the advice received, the analysis, the alternatives weighed — is what makes the defense available, and it must be documented contemporaneously.

Low-threshold plans adopted rapidly have drawn scrutiny. A plan aimed at a genuine creeping-control threat is defensible; one aimed at preventing a shareholder from advocating for change is on much weaker ground.

Action affecting the vote is scrutinized most severely. Where a board acts for the primary purpose of impeding the shareholder franchise, a compelling justification is required and is rarely found. Do not move the meeting date to disadvantage a dissident, expand the board mid-contest, adopt bylaws that change the rules after a nomination, or delay counting votes.

Consider an independent committee to consider and adopt any defensive measure where management's position is at issue.

And weigh the cost. A defensive measure that succeeds legally and alienates the institutional base has lost the campaign that matters.

Step 9 — Run the contest, if it goes to a vote

Two proxy cards, each listing all nominees. Universal proxy requires that each side's card include every duly nominated candidate, with prescribed formatting and reference requirements and minimum solicitation thresholds for the dissident. Get the mechanics right; a defect creates a fight you did not need.

Solicit relentlessly. The solicitor's job is reaching holders, chasing votes, and — in the final week — knowing where the vote stands and who has not voted.

Keep the message consistent across the proxy statement, the presentations, the letters, and every executive conversation.

Manage the litigation — challenges to the nomination notice, to disclosure adequacy, to group formation under 15 U.S.C. § 78m(d), and to defensive measures. It shapes the narrative more than the outcome, and a claim that fails publicly strengthens the other side.

Watch the mechanics at the end: inspectors of election, proxy revocation, the treatment of broker non-votes, and the record of what was received when. Close contests are decided here.

And keep running the company. A board that freezes for six months has proved the activist's point.

Step 10 — Live with the outcome

If an activist director joins, onboard them like any other director — same orientation, same materials, same access. A company that treats an appointed director as an adversary creates the dysfunction it feared and hands the fund its next campaign.

Address the information-sharing question per the settlement agreement, and understand the fund's trading constraints: a designee's knowledge may be attributed to the fund, materially limiting its ability to trade. Some funds take an observer seat or nominate a non-affiliated director for exactly this reason.

Expect the substantive argument to continue, particularly in whichever committee the appointee joined. That is normal.

Calendar the standstill dates — expiry, the next nomination window, and any fall-away triggers.

And execute what you committed to. The single most common cause of a second campaign is a company that settled the first and did not do what it said it would.

If the contest was won, do not treat the result as vindication. A campaign that reached a vote means a meaningful share of shareholders were persuadable, and the arguments will return with the next filing.

Debrief either way: what the campaign cost, which arguments landed, what the register looks like now, and what the annual self-assessment should have caught.

Step 2B — Communicating with employees, customers, and suppliers

A campaign is public, and the company's other constituencies read the same filings the shareholders do.

Employees will know within days. Send a short, accurate internal message: a shareholder has taken a position and made suggestions, the board is evaluating them, the company's strategy and everyone's job is to keep executing, and nobody outside the named spokespeople speaks to press, analysts, or the fund. Name the contact for questions.

Do not promise outcomes. A message assuring employees that nothing will change is a message that will be contradicted if the company settles, and it will be quoted back.

Recognize the retention risk. Key employees update their resumes when a campaign is public, and recruiters call. Where retention matters, address it deliberately rather than hoping — but be careful: retention awards granted during a campaign are scrutinized as entrenchment, and the compensation committee should document the business rationale and the timing.

Customers and suppliers will ask. Give the commercial teams a short, approved answer — the company continues to operate normally, the strategy is unchanged, and their contracts and service are unaffected — and a rule to route anything further to a named person. Competitors will use the campaign in sales conversations; a prepared answer neutralizes it.

Remember the solicitation rules reach these communications too. Under Section 14(a), 15 U.S.C. § 78n(a) and the rules at 17 C.F.R. Part 240, a communication reasonably calculated to result in the procurement of a proxy is a solicitation — and employee and customer communications about the campaign can qualify, particularly where employees are shareholders. Route them through the same approval path.

And keep the tone consistent with what you are telling shareholders. A defiant internal message and a measured public statement are the same company speaking, and both will be read.

Step 3B — Working with the proxy advisory firms

The advisory firms do not vote, and their recommendations move enough institutional votes that both sides treat them as a constituency.

Understand what they are doing. They apply published, largely mechanical policies to a factual record — performance against peers, governance structure, board composition and tenure, compensation alignment, and responsiveness to prior shareholder votes — and then exercise judgment on the specific dispute. They are analytical rather than adversarial, and they are persuaded by evidence.

Know the policies before the campaign. Each firm publishes its approach annually. A company that knows how its board classification, its tenure profile, and its compensation structure will be scored can address the issues in an ordinary year, when a change looks like governance rather than defense.

Prepare a substantive submission. Not a marketing deck. The segment economics, the capital allocation record with realized returns, the board skills matrix mapped to the strategy, the specific steps taken and their timing, and a direct engagement with the activist's strongest argument. Where the company has already acted on a criticism, show when — the timing matters, because action after the campaign begins is discounted.

Submit early enough to be considered, and follow the firms' stated processes for engagement and for responding to a draft report.

Address the individual directors. Under universal proxy the firms assess nominees individually, and a recommendation to withhold from a specific incumbent is now the ordinary shape of an adverse report. Anticipate which director is vulnerable and address that record specifically.

Respond to a draft report factually. Where it contains an error, correct it with the source, promptly and without argument about characterization.

And accept an adverse recommendation without breaking discipline. Attacking the advisers publicly is a recognizable move that persuades nobody and confirms the impression of a board with no answer on the merits.

Step 4B — Running the tabletop before you need it

The preparedness exercise that surfaces the most problems is a simulated campaign, and it takes half a day.

The scenario. A Schedule 13D lands on a Tuesday morning disclosing 6.5% and a purpose that includes board composition. Distribute nothing in advance.

Then run the first seventy-two hours in real time. Who convenes the team, and how long does it take? Who reads the filing and produces the assessment? Who briefs the board, and in what form? What goes out publicly, approved by whom? Who calls the top ten holders, and does anyone have those relationships?

Inject complications. The chief executive is travelling. A journalist calls before the board is briefed. An executive posts something on social media. A large holder's portfolio manager calls to say they are sympathetic to the activist. The advance notice deadline turns out to be eleven days away.

What the exercise reliably reveals: nobody is sure who approves public statements; the response team list is stale; the advance notice bylaws have not been read in three years; there is no current vote model and no relationship with the governance teams at the largest holders; and the board's own self-assessment identified two of the activist's arguments a year ago and nothing was done.

Debrief honestly and fix the findings. Update the response team and the contact list; confirm the approval path; refresh the bylaws in an ordinary year; build the vote model template; and put the unaddressed self-assessment findings back in front of the board with a date.

Run it every two years, and after any significant change in the register, the strategy, or the board.

And include the directors. A board that has worked through a simulated campaign makes better decisions in a real one — and, more usefully, tends to act on the self-assessment findings it had previously deferred.

Step 5B — Reading the register and the surveillance

Knowing who owns the company is the first operational advantage, and most companies know less than they think.

What the public record gives you. Institutional holdings reports, filed quarterly with a lag, showing positions as of a past date. Schedule 13D and 13G filings for holders above five percent, and Section 16 filings for insiders and ten percent holders. Useful, and always stale.

What surveillance adds. A stock surveillance provider analyzes settlement and custodial data to identify accumulation in near real time, frequently identifying a building position weeks before any filing obligation arises. For a company that considers itself a plausible target, this is inexpensive and it is the earliest warning available.

What to watch for: unusual volume without news; accumulation concentrated at a single prime broker; a holder converting from Schedule 13G to 13D — which signals a change from passive to active intent; options and swap activity suggesting economic exposure beyond the reported share position; and coordinated timing across several accounts.

Understand the hedging point. Cash-settled derivatives give economic exposure without voting power, and the counterparties holding the hedge are themselves a source of votes. A holder's reported share position may materially understate its economic interest — or, where it is hedged, materially overstate it.

Map the decision-makers, not just the institutions. At the large index funds the vote is decided by a governance team applying published policies, not by the portfolio manager who bought the stock. Know both, and know which one to call.

Refresh quarterly, and more often when something is moving. And put the register in front of the board once a year, because directors who do not know who owns the company cannot evaluate a campaign when one arrives.

Step 6A — The annual self-assessment, in detail

The preparedness step that returns the most is running the activist's analysis on yourself, and it is worth specifying.

Performance. Total shareholder return over one, three, and five years, against a defensible peer set and against the relevant index. Where the company trails, know why, and know whether the explanation would satisfy a skeptical analyst.

The sum of the parts. Value each segment on comparable multiples. Where the parts exceed the whole by a meaningful margin, that is the campaign thesis — and the company should either have a reasoned answer about separation costs, dis-synergies, and tax leakage, or a plan.

Capital allocation. Every material acquisition over five years, with the returns actually achieved. Buybacks and their timing. Dividend policy. Capital expenditure versus depreciation. This is where activists find the most material and where boards are least prepared to answer specifically.

Margins. Gross and operating margins against the closest comparable operators, by segment. An unexplained gap is an argument.

The board. Tenure distribution, skills matrix against the strategy, attendance, overboarding, diversity of experience, and — the question universal proxy makes urgent — which individual directors would be vulnerable head to head against a credible outside nominee.

Compensation. Realized pay against performance, peer positioning, metric selection, and anything an adviser would flag.

Governance features an adviser would criticize: classification, supermajority provisions, absence of a special meeting right, dual class without a sunset, and responsiveness to prior shareholder votes.

Then do the honest part. Rank the findings by how damaging they would be in a public campaign, and put the top three in front of the board with a remediation plan and a date. The company that acts on its own assessment does not meet these arguments publicly — and the company that files the assessment and does nothing pays for it twice.

Step 7A — The group question, investigated properly

Whether the accumulating funds are a group under 15 U.S.C. § 78m(d) is the most litigated question in activism, and it should be investigated before it is asserted.

What to develop. Trading patterns — timing, size, and venue of purchases across the suspected participants. Common prime brokers or executing counterparties. Overlapping filings and prior campaigns run together. Public statements and appearances. Communications, where obtainable.

What the law requires. A group exists where two or more persons act as a partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities. Parallel conduct is not enough; an agreement to act in concert is. Communications about a company, without an agreement respecting the securities, have been held insufficient — and the rules have been amended to address when coordinated conduct forms a group and how certain communications are treated. Research this currently rather than from memory.

Why the consequence matters. If a group existed earlier than disclosed, disclosure was late, and every share acquired after the deadline was acquired in violation — which supports injunctive relief and a sterilization remedy in the right case.

And why to be careful. A group claim that fails publicly strengthens the activist: it reads as a technical attack by a board with no answer on the merits, it consumes the company's credibility with the institutions, and it invites a counterclaim about the board's own disclosure.

The disciplined approach. Develop the record, preserve it, and assert only where the evidence is genuinely strong or where the disclosure deficiency is independently material. Where it is not, keep the analysis in the file — it may become useful if the accumulation continues, and it costs nothing to hold.

Step 8A — Budget, advisers, and what it costs

A contested campaign is expensive, and the cost is the main input into the settlement decision. Model it early.

The advisers. Outside counsel for the securities and governance work; separate Delaware counsel where the corporate law questions are live; a financial adviser; a proxy solicitor, whose job is reaching holders and chasing votes; a communications firm; and, where the register is opaque, a stock surveillance provider.

The direct costs. Solicitation is the largest variable — retail outreach in particular — followed by legal, financial advisory, communications, and printing and mailing. A contested campaign that runs to a vote at a mid-cap company routinely costs several million dollars, and a settlement reached early costs a fraction of that.

The activist's expenses. Funds routinely request reimbursement as part of a settlement, and companies routinely pay some portion. Treat it as a negotiated line item rather than a principle.

The indirect costs, which are larger. Senior management attention for three to six months, at exactly the time the company needs to be executing. Board time. Employee distraction and recruiting difficulty while the outcome is public. And customer and supplier questions.

Insurance. Notify the D&O carriers early. Coverage for a proxy contest is limited — most policies do not cover the company's solicitation costs — but defense costs for individual directors in related litigation may be covered, and late notice is an avoidable forfeiture.

Model the settlement alternative explicitly. Two board seats and a strategic review, versus several million dollars, four months of management attention, and a vote the model says is close. Presented that way, the settlement decision becomes a business judgment rather than a matter of pride — which is the point.

Step 9A — Managing the board through the campaign

Directors experience an activist campaign as a challenge to their competence, and managing that is a substantial part of counsel's job.

Increase the cadence and keep it structured. Weekly updates during an active campaign, in writing, with the vote model, the engagement log, and the upcoming decisions. Directors who are informed do not freelance.

Name the decision points in advance: whether to challenge the nomination notice, whether to adopt a defensive measure, whether to settle and on what terms, and — if it goes to a vote — the solicitation budget. A board that sees these coming decides better than one presented with a recommendation and a deadline.

Manage the individual exposure. Under universal proxy each incumbent is individually at risk, and a director who learns from the vote model that they are the weakest link needs to hear it privately, from the lead director or the chair, before it appears in an adviser's report. Some will choose not to stand — which is frequently the right outcome and should be handled with dignity rather than as a defeat.

Watch the conflicts. A director facing non-renomination has a personal interest in the response; so does an executive whose strategy is under attack. Name them, manage them, and record the management.

Keep the independent directors in charge of the response where management's position is at issue, with their own advisers. In any campaign involving a call for a sale, this is not optional.

Discipline the communications. A director speaking to a shareholder, a journalist, or a peer without coordination creates a solicitation problem under Section 14(a), 15 U.S.C. § 78n(a) and a message problem simultaneously. One channel, one approver.

And protect the ordinary work. The audit committee still has a quarter to review, the compensation committee still has a cycle to run. A board consumed by the campaign has proved the activist's point about oversight.

Step 10A — Handling the campaigns that are not proxy contests

Most activist engagement never becomes a contested election, and each variant is handled differently.

The private letter. Take it seriously and answer it substantively. A dismissive reply is the most reliable way to convert a private conversation into a public campaign, and the letter usually contains the argument the company would face in a proxy fight. Meet the fund. Ask questions. Where the analysis is wrong, show why with data; where it is right, say so.

The shareholder proposal. A holder meeting the eligibility and procedural requirements may submit a proposal for inclusion in the proxy statement, and the company may seek exclusion on defined substantive bases by engaging the staff. Run the cost-benefit: a fight over exclusion frequently costs more than the proposal, and negotiated withdrawal in exchange for a commitment is the ordinary and usually better outcome.

The withhold or vote-no campaign. No slate, no contest, low cost to the activist — and under a majority voting standard in an uncontested election, a director receiving more withhold than for votes tenders a resignation the board must consider. Treat it as a real threat, identify the targeted directors' vulnerabilities, and engage.

The books and records demand. A holder with a proper purpose may inspect specified records, and activists use this to build a record before a campaign or a suit. Respond carefully: over-refusal produces litigation the company frequently loses; over-production supplies the campaign. Negotiate scope and a confidentiality undertaking.

The say-on-pay campaign, which is easier to win than a board contest and is frequently a precursor. A failed or weakly supported vote is an obligation to engage and to disclose the response.

And the policy-driven proposal, which is a different exercise from an economic campaign: engage the specific concern rather than defending performance, because performance is not what is being questioned.

Step 11 — How Pemberton's six months ran

Month 0. Surveillance flagged accumulation across three accounts at a single prime broker.

Month 1. Ashcombe Partners filed a Schedule 13D disclosing 7.1% and a purpose including board composition and strategic alternatives. Delacroix-Mbeki convened the pre-named response team the same day, briefed the board in writing within twenty-four hours, and issued a two-sentence acknowledgment.

Month 1. Counsel developed the trading record on the two parallel accumulators. The pattern was suggestive and did not establish an agreement to act in concert. The company preserved the analysis and did not sue — a group claim that fails publicly strengthens the activist.

Month 2. The board's private assessment concluded that two of Ashcombe's four arguments were right, and that its own analysis nine months earlier had said the same thing.

Month 2. Ashcombe nominated three directors. The notice was compliant. Counsel advised against a technical challenge.

Month 3. The vote model, built holder by holder, showed the company comfortably ahead on two of the three seats and genuinely at risk on the third — where the incumbent was a sixteen-year director with no chemicals experience, individually exposed under universal proxy against a former operating executive from a larger competitor.

Months 3–4. Engagement: all top twenty holders, governance teams at the three largest index funds, and a substantive submission to the proxy advisers built on segment returns and the board skills matrix.

Month 4. The board asked the settlement question. Would it appoint the former operating executive if Ashcombe did not exist? Yes. The Ashcombe partner? No.

Month 5 — settlement. One Ashcombe nominee appointed, one mutually agreed independent added, two long-tenured directors not renominated, a strategic review of the coatings segment announced with a defined timetable, and an eighteen-month standstill with a voting commitment limited to director elections. Committee seats took a week to negotiate; both new directors joined the strategy committee.

Cost: about $5.2 million and four months of senior management attention.

Delacroix-Mbeki's assessment: "Our own self-assessment identified the same two problems nine months earlier. The entire campaign was the price of not acting on it."